Debt-to-equity of Zomedica Corp. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Zomedica Corp. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Zomedica Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 7.8%, a 45% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Zomedica Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 7.8% +2.4% +45% 30 Sep 2025
Q2 2025 6.8% +1.5% +27% 30 Jun 2025
Q1 2025 6% +0.55% +10% 31 Mar 2025
Q4 2024 5.5% -0.31% -5.4% 31 Dec 2024
Q3 2024 5.4% -0.17% -3.1% 30 Sep 2024
Q2 2024 5.3% -0.09% -1.7% 30 Jun 2024
Q1 2024 5.5% +0.65% +13% 31 Mar 2024
Q4 2023 5.8% +1.7% +41% 31 Dec 2023
Q3 2023 5.5% +1.7% +44% 30 Sep 2023
Q2 2023 5.4% +2.3% +74% 30 Jun 2023
Q1 2023 4.8% +2.2% +83% 31 Mar 2023
Q4 2022 4.1% +2% +98% 31 Dec 2022
Q3 2022 3.8% +2% +107% 30 Sep 2022
Q2 2022 3.1% +1.2% +59% 30 Jun 2022
Q1 2022 2.6% -0.16% -5.7% 31 Mar 2022
Q4 2021 2.1% -5.3% -72% 31 Dec 2021
Q3 2021 1.9% -7.7% -80% 30 Sep 2021
Q2 2021 2% 30 Jun 2021
Q1 2021 2.8% 31 Mar 2021
Q4 2020 7.4% 31 Dec 2020
Q3 2020 9.5% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.